In Brief: Coherent
This article was originally published in The Gray Sheet
Executive Summary
Coherent: Displays its VersaPulse solid-state aesthetic laser system at the American Academy of Dermatology meeting Feb. 10-15 in Washington, D.C. A 510(k) for the device, submitted in December, is expected to be cleared in March. The device offers three different Q-switched wavelengths for treatment of pigmented lesions and tattoo removal and also offers a "variable pulse width green wavelenth for vascular lesions"...
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.